 |
PDBsum entry 3ml2
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Lyase/lyase inhibitor
|
PDB id
|
|
|
|
3ml2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Coumarinyl-Substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations.
|
 |
|
Authors
|
 |
J.Wagner,
B.S.Avvaru,
A.H.Robbins,
A.Scozzafava,
C.T.Supuran,
R.Mckenna.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2010,
18,
4873-4878.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
We investigated a series of coumarinyl-substituted aromatic sulfonamides as
inhibitors of four carbonic anhydrase (CA, EC 4.2.1.1) isoforms with medical
applications, the cytosolic hCA I, and II, and the transmembrane,
tumor-associated hCA IX and XII. Compounds incorporating
7-methoxy-coumarin-4-yl-acetamide-tails and benzenesulfonamide and
benzene-1,3-disulfonamide scaffolds showed medium potency inhibition of hCA I
(K(I)s of 73-131nM), effective hCA II inhibition (K(I)s of 9.1-36nM) and less
effective hCA IX and XII inhibition (K(I)s of 55-128nM). Only one compound, the
derivatized 4-amino-6-trifluoromethyl-benzene-1,3-disulfonamide with the
coumarinyl tail, showed effective inhibition of the transmembrane isoforms, with
K(I)s of 5.9-14.2nM, although it was less effective as hCA I and II inhibitor
(K(I)s of 36-120nM). An X-ray crystal structure of hCA II in complex with
4-(7-methoxy-coumarin-4-yl-acetamido)-benzenesulfonamide (K(I) of 9.1nM against
hCA II) showed the intact inhibitor coordinated to the zinc ion from the enzyme
active site by the sulfonamide moiety, and participating in a edge-to-face
stacking with Phe131, in addition to other hydrophobic and hydrophilic
interactions with water molecules and amino acid residues from the active site.
Thus, sulfonamides incorporating coumarin rings have a distinct inhibition
mechanism compared to the coumarins, and may lead to compounds with interesting
inhibition profiles against various alpha-CAs found in mammals or parasites,
such as Plasmodium falciparum.
|
 |
|
|
|
|
 |